XML 46 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Derivative Financial Instruments
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Derivative Financial Instruments

21. Derivative Financial Instruments

At December 31, 2022 and 2021, the Company’s derivative financial instruments consist of interest rate swaps. The Company’s interest rate swaps are used for three purposes: 1) to mitigate the Company’s exposure to rising interest rates on certain fixed rate loans totaling $273.6 million and $299.6 million at December 31, 2022 and December 31, 2021, respectively; 2) to facilitate risk management strategies for our loan customers with $221.2 million of swaps outstanding, which include $110.6 million with customers and $110.6 million with bank counterparties at December 31, 2022 and $228.0 million of swaps outstanding, which include $114.0 million with customers and $114.0 million with bank counterparties at December 31, 2021; and 3) to mitigate exposure to rising interest rates on certain short-term advances and brokered CDs totaling $871.5 million and $996.5 million at December 31, 2022 and December 31, 2021, respectively.

The Company’s derivative instruments are carried at fair value in the Company’s financial statements as part of Other assets for derivatives with positive fair values and Other liabilities for derivatives with negative fair values. The accounting for changes in the fair value of a derivative instrument is dependent upon whether or not it qualifies and has been designated as a hedge for accounting purposes, and further, by the type of hedging relationship.

At December 31, 2022 and 2021, we held derivatives designated as cash flow hedges, fair value hedges and certain derivatives not designated as hedges.

At December 31, 2022 and 2021, derivatives with a combined notional amount of $221.2 million and $228.0 million, respectively, were not designated as hedges. At December 31, 2022 and 2021, derivatives with a combined notional amount of $273.6 million and $299.6 million were designated as fair value hedges. At December 31, 2022 and 2021, derivatives with a combined notional amount of $871.5 million and $996.5 million, respectively, were designated as cash flow hedges.

For cash flow hedges, the changes in the fair value of the derivative is reported in accumulated other comprehensive income (loss), net of tax. Amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same period during which the hedged forecasted transaction effects earnings. During the year ended December 31, 2022, $4.3 million was reclassified from accumulated other comprehensive income (loss) to interest expense. The estimated amount to be reclassified in next 12 months out of accumulated other comprehensive income (loss) into earnings is $9.0 million.

Changes in the fair value of interest rate swaps not designated as hedges are reflected in “Net loss from fair value adjustments” in the Consolidated Statements of Income.

The following table sets forth information regarding the Company’s derivative financial instruments at the periods indicated:

    

December 31, 2022

    

December 31, 2021

Notional

Notional

    

Amount

    

Fair Value (1)

    

Amount

    

Fair Value (1)

(In thousands)

Interest rate swaps (cash flow hedge)

$

700,750

$

31,716

$

355,000

$

7,328

Interest rate swaps (fair value hedge)

273,607

24,673

Interest rate swaps (non-hedge)

110,598

18,197

113,988

3,355

Interest rate swaps (cash flow hedge)

 

170,750

 

(210)

 

641,500

 

(9,387)

Interest rate swaps (fair value hedge)

 

 

 

299,555

 

(12,329)

Interest rate swaps (non-hedge)

 

110,598

 

(18,197)

 

113,988

 

(3,355)

Total derivatives

$

1,366,303

$

56,179

$

1,524,031

$

(14,388)

(1)Derivatives in a net positive position are recorded as “Other assets” and derivatives in a net negative position are recorded as “Other liabilities” in the Consolidated Statements of Financial Condition.

The following table presents information regarding the Company’s fair value hedged items for the periods indicated:

Cumulative Amount

of the Fair Hedging Adjustment

Line Item in the Consolidated

Carrying Amount of the

Included in the Carrying Amount of

Statement of Financial Condition in

Hedged Assets

the Hedged Assets

Which the Hedged Item is Included

At December 31,

At December 31,

(In thousands)

2022

2021

2022

2021

Loans:

Multi-family residential

$

82,613

$

113,730

$

(10,480)

$

7,608

Commercial real estate

167,353

192,694

(15,442)

3,477

Commercial business and other

6,298

122

Total

$

249,966

$

312,722

$

(25,922)

$

11,207

The following table sets forth the effect of derivative instruments on the Consolidated Statements of Income for the periods indicated:

    

    

For the years ended

December 31, 

(In thousands)

Affected Line Item in the Statements Where Net Income is Presented

    

    

2022

    

2021

    

2020

Financial Derivatives:

 

 

  

 

  

 

  

Other interest expense

$

-

$

(305)

$

(434)

Net gain (loss) from fair value adjustments

-

978

(2,325)

Interest rate swaps (non-hedge)

-

673

(2,759)

Interest rate swaps (fair value hedge)

Interest and fees on loans

96

(3,481)

(5,226)

Other interest expense

(2,218)

 

(10,554)

 

(6,703)

Deposit

2,504

(139)

-

Interest rate swaps (cash flow hedge)

286

(10,693)

(6,703)

Net income (loss)

$

382

$

(13,501)

$

(14,688)

The Company’s interest rate swaps are subject to master netting arrangements between the Company and its three designated counterparties. The Company has not made a policy election to offset its derivative positions. The interest rate swaps with borrowers are cross collateralized with the underlying loan and, therefore, there is no posted collateral. Interest rate swap agreements with third-party counterparties contain provisions that require the Company to post collateral if the derivative exposure exceeds a threshold amount and receive collateral for agreements in a net asset position.

The following tables present the effect of the master netting arrangements on the presentation of the derivative assets and liabilities in the Consolidated Statements of Condition as of the dates indicated:

December 31, 2022

Gross Amounts Not Offset in the

Consolidated Statements of

Gross Amount Offset in

Net Amount of Assets

Financial Condition

Gross Amount of

the Statements

Presented in the

Financial

Cash Collateral

(In thousands)

    

Recognized Assets

    

of Condition

    

Statements of Condition

    

Instruments

    

Received

    

Net Amount

 

Interest rate swaps

$

74,586

$

$

74,586

$

$

72,185

 

$

2,401

Gross Amounts Not Offset in the

Consolidated Statements of

Gross Amount of

Gross Amount Offset in

Net Amount of Liabilities

Financial Condition

Recognized

the Statements

Presented in the

Financial

Cash Collateral

(In thousands)

    

Liabilities

    

of Condition

    

Statements of Condition

    

Instruments

    

Pledged

    

Net Amount

 

Interest rate swaps

$

18,407

$

$

18,407

$

$

 

$

18,407

December 31, 2021

Gross Amounts Not Offset in the

Consolidated Statements of

Gross Amount Offset in

Net Amount of Assets

Financial Condition

Gross Amount of

the Statements

Presented in the

Financial

Cash Collateral

(In thousands)

    

Recognized Assets

    

of Condition

    

Statements of Condition

    

Instruments

    

Received

    

Net Amount

 

Interest rate swaps

$

10,683

$

$

10,683

$

$

 

$

10,683

Gross Amounts Not Offset in the

Consolidated Statements of

Gross Amount of

Gross Amount Offset in

Net Amount of Liabilities

Financial Condition

Recognized

the Statements

Presented in the

Financial

Cash Collateral

(In thousands)

    

Liabilities

    

of Condition

    

Statements of Condition

    

Instruments

    

Pledged

    

Net Amount

 

Interest rate swaps

$

25,071

$

$

25,071

$

$

21,527

 

$

3,544

Correction of an Error on the Consolidated Statements of Cash Flows

 

The Company identified an error in its consolidated statements of cash flows as of September 30, 2022 and June 30, 2022 for the change in cash collateral related to certain derivative financial instruments. The Company determined that for the nine months ended September 30, 2022 and six months ended June 30, 2022, the change in cash collateral amount was understated. The Company reviewed the impact of this error on the prior periods and determined that the error was not material to the prior period consolidated financial statements. The impact of the error as corrected decreased net cash used in investing activities by $25.1 million and $16.7 million for the nine months ended September 30, 2022 and six months ended June 30, 2022, respectively, and increased the net increase in cash, cash equivalents and restricted cash by equivalent amounts.